These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 17376685)

  • 21. Congenital myopathies: not only a paediatric topic.
    Jungbluth H; Voermans NC
    Curr Opin Neurol; 2016 Oct; 29(5):642-50. PubMed ID: 27538056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subtle central and peripheral nervous system abnormalities in a family with centronuclear myopathy and a novel dynamin 2 gene mutation.
    Echaniz-Laguna A; Nicot AS; Carré S; Franques J; Tranchant C; Dondaine N; Biancalana V; Mandel JL; Laporte J
    Neuromuscul Disord; 2007 Dec; 17(11-12):955-9. PubMed ID: 17825552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A centronuclear myopathy-dynamin 2 mutation impairs skeletal muscle structure and function in mice.
    Durieux AC; Vignaud A; Prudhon B; Viou MT; Beuvin M; Vassilopoulos S; Fraysse B; Ferry A; Lainé J; Romero NB; Guicheney P; Bitoun M
    Hum Mol Genet; 2010 Dec; 19(24):4820-36. PubMed ID: 20858595
    [TBL] [Abstract][Full Text] [Related]  

  • 24. "Necklace" fibers, a new histological marker of late-onset MTM1-related centronuclear myopathy.
    Bevilacqua JA; Bitoun M; Biancalana V; Oldfors A; Stoltenburg G; Claeys KG; Lacène E; Brochier G; Manéré L; Laforêt P; Eymard B; Guicheney P; Fardeau M; Romero NB
    Acta Neuropathol; 2009 Mar; 117(3):283-91. PubMed ID: 19084976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phenotype variability and histopathological findings in centronuclear myopathy due to DNM2 mutations.
    Hanisch F; Müller T; Dietz A; Bitoun M; Kress W; Weis J; Stoltenburg G; Zierz S
    J Neurol; 2011 Jun; 258(6):1085-90. PubMed ID: 21221624
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy.
    Fischer D; Herasse M; Bitoun M; Barragán-Campos HM; Chiras J; Laforêt P; Fardeau M; Eymard B; Guicheney P; Romero NB
    Brain; 2006 Jun; 129(Pt 6):1463-9. PubMed ID: 16585051
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defects in amphiphysin 2 (BIN1) and triads in several forms of centronuclear myopathies.
    Toussaint A; Cowling BS; Hnia K; Mohr M; Oldfors A; Schwab Y; Yis U; Maisonobe T; Stojkovic T; Wallgren-Pettersson C; Laugel V; Echaniz-Laguna A; Mandel JL; Nishino I; Laporte J
    Acta Neuropathol; 2011 Feb; 121(2):253-66. PubMed ID: 20927630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Central core disease is due to RYR1 mutations in more than 90% of patients.
    Wu S; Ibarra MC; Malicdan MC; Murayama K; Ichihara Y; Kikuchi H; Nonaka I; Noguchi S; Hayashi YK; Nishino I
    Brain; 2006 Jun; 129(Pt 6):1470-80. PubMed ID: 16621918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. De novo RYR1 heterozygous mutation (I4898T) causing lethal core-rod myopathy in twins.
    Hernandez-Lain A; Husson I; Monnier N; Farnoux C; Brochier G; Lacène E; Beuvin M; Viou M; Manéré L; Claeys KG; Fardeau M; Lunardi J; Voit T; Romero NB
    Eur J Med Genet; 2011; 54(1):29-33. PubMed ID: 20888934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamin 2 mutations cause sporadic centronuclear myopathy with neonatal onset.
    Bitoun M; Bevilacqua JA; Prudhon B; Maugenre S; Taratuto AL; Monges S; Lubieniecki F; Cances C; Uro-Coste E; Mayer M; Fardeau M; Romero NB; Guicheney P
    Ann Neurol; 2007 Dec; 62(6):666-70. PubMed ID: 17932957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adult course in dynamin 2 dominant centronuclear myopathy with neonatal onset.
    Melberg A; Kretz C; Kalimo H; Wallgren-Pettersson C; Toussaint A; Böhm J; Stålberg E; Laporte J
    Neuromuscul Disord; 2010 Jan; 20(1):53-6. PubMed ID: 19932619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutations in dynamin 2 cause dominant centronuclear myopathy.
    Bitoun M; Maugenre S; Jeannet PY; Lacène E; Ferrer X; Laforêt P; Martin JJ; Laporte J; Lochmüller H; Beggs AH; Fardeau M; Eymard B; Romero NB; Guicheney P
    Nat Genet; 2005 Nov; 37(11):1207-9. PubMed ID: 16227997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Centronuclear myopathies: genotype-phenotype correlation and frequency of defined genetic forms in an Italian cohort.
    Fattori F; Maggi L; Bruno C; Cassandrini D; Codemo V; Catteruccia M; Tasca G; Berardinelli A; Magri F; Pane M; Rubegni A; Santoro L; Ruggiero L; Fiorini P; Pini A; Mongini T; Messina S; Brisca G; Colombo I; Astrea G; Fiorillo C; Bragato C; Moroni I; Pegoraro E; D'Apice MR; Alfei E; Mora M; Morandi L; Donati A; Evilä A; Vihola A; Udd B; Bernansconi P; Mercuri E; Santorelli FM; Bertini E; D'Amico A
    J Neurol; 2015 Jul; 262(7):1728-40. PubMed ID: 25957634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ryanodine receptor mutations in malignant hyperthermia and central core disease.
    McCarthy TV; Quane KA; Lynch PJ
    Hum Mutat; 2000; 15(5):410-7. PubMed ID: 10790202
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adult centronuclear myopathies: A hospital-based study.
    Echaniz-Laguna A; Biancalana V; Böhm J; Tranchant C; Mandel JL; Laporte J
    Rev Neurol (Paris); 2013; 169(8-9):625-31. PubMed ID: 23938035
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Centronuclear myopathies: a widening concept.
    Romero NB
    Neuromuscul Disord; 2010 Apr; 20(4):223-8. PubMed ID: 20181480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Centronuclear myopathy with cataracts due to a novel dynamin 2 (DNM2) mutation.
    Jungbluth H; Cullup T; Lillis S; Zhou H; Abbs S; Sewry C; Muntoni F
    Neuromuscul Disord; 2010 Jan; 20(1):49-52. PubMed ID: 19932620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Autosomal recessive inheritance of RYR1 mutations in a congenital myopathy with cores.
    Jungbluth H; Müller CR; Halliger-Keller B; Brockington M; Brown SC; Feng L; Chattopadhyay A; Mercuri E; Manzur AY; Ferreiro A; Laing NG; Davis MR; Roper HP; Dubowitz V; Bydder G; Sewry CA; Muntoni F
    Neurology; 2002 Jul; 59(2):284-7. PubMed ID: 12136074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A diagnostic dilemma in a family with cystinuria type B resolved by muscle magnetic resonance.
    Astrea G; Munteanu I; Cassandrini D; Lillis S; Trovato R; Pegoraro E; Cioni G; Mercuri E; Muntoni F; Battini R
    Pediatr Neurol; 2015 May; 52(5):548-51. PubMed ID: 25882082
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional properties of RYR1 mutations identified in Swedish patients with malignant hyperthermia and central core disease.
    Vukcevic M; Broman M; Islander G; Bodelsson M; Ranklev-Twetman E; Müller CR; Treves S
    Anesth Analg; 2010 Jul; 111(1):185-90. PubMed ID: 20142353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.